Page 4 - Daniel Mikol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel mikol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Mikol Today - Breaking & Trending Today

NervGen Pharma Corp.: NervGen Pharma Reports First Quarter 2021 Results

NervGen Pharma Corp.: NervGen Pharma Reports First Quarter 2021 Results
NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ( NervGen or the
Company ), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system injuries, today reported its financial results for the first quarter ended March 31, 2021.
We achieved several key milestones in the first quarter of 2021 including receiving clearance from the FDA to proceed with our Phase 1 clinical trial for our lead compound, NVG-291, which has now commenced in Australia, stated Paul Brennan, NervGen s President & CEO. In addition, we established an Alzheimer s Disease Scientific Advisory Board comprised of world-class scientists and clinical researchers in Alzheimer s disease and have decided to initiate a multi-dose Alzheimer s disease patient cohort as a Phase 1b addition to our clinical program. We also received Orphan Designation for NVG-291 from the European Med ....

United States , United Kingdom , British Columbia , Kostenloser Wertpapierhandel , Paul Brennan , Nancy Thompson , Huitt Tracey , Company Units , Linkedin Nervgen Pharma Corp , British Columbia Newsfile Corp , Nervgen Pharma Corp , Bellberry Human Research Ethics Committee , Company Annual Information Form , Corporate Communications , Companya Warrant Share , European Medicines Agency , Venture Exchange , Regulation Services Provider , Gen Pharma , Disease Scientific Advisory Board , Orphan Designation , Encode Ideas , Daniel Mikol , Chief Medical Officer , Board Certified Neurologist , Overnight Marketed Equity ,

NervGen Pharma Corp.: NervGen Pharma Announces Appointment of Pharma Veteran Dr. Daniel Mikol as Chief Medical Officer

Vancouver, British Columbia (Newsfile Corp. - April 22, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions ....

United States , United Kingdom , Thousand Oaks , British Columbia , Kostenloser Wertpapierhandel , Paul Brennan , Nancy Thompson , Huitt Tracey , Linkedin Nervgen Pharma Corp , Immunological Research , Department Of Neurology , Nervgen Pharma Corp , University Of Michigan , Global Clinical Development At Amgen , University Of Chicago , Venture Exchange , Regulation Services Provider , British Columbia Newsfile Corp , Company Annual Information Form , Corporate Communications , Health Canada , Ludwig Maximilian University Of Munich , Gen Pharma , Daniel Mikol , Chief Medical Officer , Executive Medical Director ,